Population
A 72-year-old female patient with mixed rheumatic mitral valve disease and persistent atrial fibrillation
Design
Case report
Authors
Loading...
Early postoperative thrombosis risks persist after bioprosthetic MVR in rheumatic disease with AF; hypothesis-generating for optimized perioperative anticoagulation strategies.
This case highlights the potential hazard and mechanisms of early postoperative immunothrombosis, characterized by NET release and anticoagulant resistance, following bioprosthetic mitral valve replacement.
Kostyunin et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: